Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Non-Current Assets (2023 - 2026)

Adagio Medical Holdings has reported Non-Current Assets over the past 4 years, most recently at $23.5 million for Q1 2026.

  • Quarterly Non-Current Assets fell 2.14% to $23.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $93.7 million through Mar 2026, down 22.5% year-over-year, with the annual reading at $23.2 million for FY2025, 0.31% changed from the prior year.
  • Non-Current Assets was $23.5 million for Q1 2026 at Adagio Medical Holdings, up from $23.2 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $72.2 million in Q3 2024 and troughed at $1.6 million in Q4 2023.
  • The 4-year median for Non-Current Assets is $23.4 million (2025), against an average of $26.8 million.
  • Year-over-year, Non-Current Assets surged 1308.48% in 2024 and then plummeted 67.57% in 2025.
  • A 4-year view of Non-Current Assets shows it stood at $1.6 million in 2023, then surged by 1308.48% to $23.1 million in 2024, then rose by 0.31% to $23.2 million in 2025, then grew by 1.22% to $23.5 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Non-Current Assets are $23.5 million (Q1 2026), $23.2 million (Q4 2025), and $23.4 million (Q3 2025).